ECO Animal Health Group PLC banner
E

ECO Animal Health Group PLC
LSE:EAH

Watchlist Manager
ECO Animal Health Group PLC
LSE:EAH
Watchlist
Price: 107 GBX 4.9%
Market Cap: £72.5m

ECO Animal Health Group PLC
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

ECO Animal Health Group PLC
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
E
ECO Animal Health Group PLC
LSE:EAH
Total Equity
£84.8m
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
1%
GlaxoSmithKline PLC
LSE:GSK
Total Equity
£16.4B
CAGR 3-Years
16%
CAGR 5-Years
2%
CAGR 10-Years
12%
AstraZeneca PLC
LSE:AZN
Total Equity
$48.7B
CAGR 3-Years
10%
CAGR 5-Years
26%
CAGR 10-Years
10%
Hikma Pharmaceuticals PLC
LSE:HIK
Total Equity
$2.3B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
6%
Allergy Therapeutics PLC
LSE:AGY
Total Equity
-£28.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
Alliance Pharma PLC
LSE:APH
Total Equity
£207.6m
CAGR 3-Years
-10%
CAGR 5-Years
-5%
CAGR 10-Years
11%
No Stocks Found

ECO Animal Health Group PLC
Glance View

Market Cap
72.5m GBX
Industry
Pharmaceuticals

ECO Animal Health Group Plc engages in the development, registration and marketing of pharmaceutical products for animals. The company is headquartered in New Malden, Surrey and currently employs 207 full-time employees. The firm's segments include UK, China and Japan, North America, South and South East Asia, Latin America, Europe and the Rest of the World. The firm's principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. Its products include Aivlosin, Ecomectin and others. Aivlosin is a macrolide antibiotic for treatment of respiratory and enteric diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. Its Ecoheart, Ecotraz and Ecomintic are for the treatment and prevention of parasites in cattle, sheep, pigs, horses and dogs.

EAH Intrinsic Value
91.18 GBX
Overvaluation 15%
Intrinsic Value
Price
E

See Also

What is ECO Animal Health Group PLC's Total Equity?
Total Equity
84.8m GBP

Based on the financial report for Sep 30, 2025, ECO Animal Health Group PLC's Total Equity amounts to 84.8m GBP.

What is ECO Animal Health Group PLC's Total Equity growth rate?
Total Equity CAGR 10Y
1%

Over the last year, the Total Equity growth was 3%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett